This inventor holds 6 USPTO granted patents, plus 1 CIPO patent. Top assignee: New York Blood Center, Inc.. Active years: 1982-2001.
Company Filing History:
Years Active: 1982-2001
Title: Jack Goldstein: Innovator in Blood Product Enzymes
Introduction
Jack Goldstein is a prominent inventor based in New York, NY (US). He has made significant contributions to the field of biochemistry, particularly in the development of enzymes that enhance blood product safety and compatibility. With a total of 6 patents to his name, Goldstein's work is vital for improving transfusion practices.
Latest Patents
Goldstein's latest patents include the recombinant α-N-acetylgalactosaminidase enzyme and cDNA encoding said enzyme. This invention focuses on a recombinant enzyme designed for the removal of A antigens from the surface of cells in blood products. Specifically, it details methods for cloning and expressing this enzyme, as well as a technique for utilizing it to remove A antigens from blood cells. Another notable patent is for endo-β-galactosidase, which involves purified nucleic acid encoding the enzyme from Flavobacterium keratolyticus. This enzyme can be used to de-antigenize human erythrocytes bearing A1 antigen, making it possible to transfuse these erythrocytes into individuals who cannot tolerate type A1 blood.
Career Highlights
Goldstein is currently employed at the New York Blood Center, Inc., where he continues to innovate in the field of blood product safety. His work has been instrumental in advancing the understanding and application of recombinant enzymes in transfusion medicine.
Collaborations
Some of his notable coworkers include Alex Zhu and Lin Leng, who contribute to the collaborative efforts in research and development at the New York Blood Center.
Conclusion
Jack Goldstein's contributions to the field of biochemistry and blood product safety through his innovative patents are invaluable. His work not only enhances transfusion practices but also paves the way for future advancements in medical science.